Capha Pharmaceuticals's market cap is currently $64.00. The company's EPS TTM is $0; its P/E ratio is ―; Capha Pharmaceuticals is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	-	-	-	-	-
Operating Income	C$ -53.14K	C$ -57.89K	C$ -44.80K	C$ -50.71K	C$ -65.39K
EBITDA	C$ -53.22K	C$ -57.68K	C$ -44.49K	C$ -50.23K	C$ -64.61K
Net Income	C$ -53.36K	C$ -58.31K	C$ -44.81K	C$ -51.16K	C$ -65.29K
Balance Sheet
Cash & Short-Term Investments	C$ 671.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Total Assets	C$ 1.75K	-	-	-	-
Total Debt	C$ 489.07K	C$ 416.07K	C$ 338.07K	C$ 276.57K	C$ 0.00
Net Debt	C$ 488.40K	C$ 415.31K	C$ 335.63K	C$ 275.80K	-
Total Liabilities	C$ 501.49K	C$ 317.34K	C$ 282.01K	C$ 234.27K	C$ 179.35K
Stockholders' Equity	C$ -499.74K	C$ -315.67K	C$ -278.52K	C$ -232.05K	C$ -175.06K
Cash Flow
Free Cash Flow	C$ -73.36K	C$ -61.49K	C$ -47.38K	C$ -76.17K	C$ -44.46K
Operating Cash Flow	C$ -73.36K	C$ -61.49K	C$ -47.38K	C$ -76.17K	C$ -44.46K
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Financing Cash Flow	C$ 73.00K	C$ 59.91K	C$ 49.05K	C$ 74.93K	C$ 45.97K

Currency in CAD

Capha Pharmaceuticals Earnings and Revenue History

Income Statement >

Capha Pharmaceuticals Debt to Assets

Balance Sheet >

Capha Pharmaceuticals Cash Flow

Cash Flow >

Capha Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing